4//SEC Filing
Paulson Richard A. 4
Accession 0000950170-25-014491
CIK 0001503802other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:16 PM ET
Size
4.8 KB
Accession
0000950170-25-014491
Insider Transaction Report
Form 4
Paulson Richard A.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-02-04$0.65/sh−4,099$2,664→ 1,120,158 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001804460
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:16 PM ET
- Size
- 4.8 KB